Biosenic (LTS:0R55) Profitability Rank: 0 (As of Dec. 2025)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

What is Biosenic Profitability Rank?

Biosenic has the Profitability Rank of 0.

GuruFocus Profitability Rank ranks how profitable a company is and how likely the company's business will stay that way. It is rated on a scale of 1 to 10 and is based on these factors:

1. Operating Margin %
2. Piotroski F-Score
3. Trend of the Operating Margin % (5-year average). The company with an uptrend profit margin has a higher rank.
4. Consistency of the profitability
5. Predictability Rank

A higher score indicates superior profitability, with companies rated 7 or above considered to have more robust and sustainable profit generation. Conversely, a score of 3 or lower suggests challenges in generating consistent profits.

Biosenic's Operating Margin % for the quarter that ended in Dec. 2025 was %. As of today, Biosenic's Piotroski F-Score is 0.

Biosenic Profitability Rank Related Terms

LTS:0R55 vs VRTX, REGN, ALNY: Profitability Rank Comparison

For the Biotechnology subindustry, Biosenic's Profitability Rank, along with its competitors' market caps and Profitability Rank data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Biosenic Profitability Rank vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Biosenic's Profitability Rank distribution charts can be found below:

* The bar in red indicates where Biosenic's Profitability Rank falls into.


Biosenic Profitability Rank Calculation

GuruFocus Profitability Rank ranks how profitable a company is and how likely the company's business will stay that way.

The rank is rated on a scale of 1 to 10. A higher score indicates superior profitability, with companies rated 7 or above considered to have more robust and sustainable profit generation. Conversely, a score of 3 or lower suggests challenges in generating consistent profits.

Biosenic has the Profitability Rank of 0.

Profitability Rank is not directly related to the Financial Strength. But if a company is consistently profitable, its financial strength will be stronger.

Profitability Rank is based on these factors:

1. Operating Margin %

Operating Margin % - also known as operating income margin, operating profit margin and return on sales (ROS) - is the ratio of Operating Income divided by net sales or Revenue, usually presented in percent.

Biosenic's Operating Margin % for the quarter that ended in Dec. 2025 is calculated as:

Operating Margin %=Operating Income (Q: Dec. 2025 ) / Revenue (Q: Dec. 2025 )
=-0.935 / 0
= %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

2. Piotroski F-Score

The zones of discrimination were as such:

Good or high score = 8 or 9
Bad or low score = 0 or 1

Biosenic has an F-score of 0. It is a bad or low score, which usually implies poor business operation.

3. Trend of the Operating Margin % (5-year average). The company with an uptrend profit margin has a higher rank.

4. Consistency of the profitability

5. Predictability Rank

Biosenic Business Description

Address Rue Granbonpre 11, Batiment H (bte 24), Mont-St-Guibert, BEL, 1435
Bone Therapeutics SA, which trades under the ticker BNZPF, is a Belgian clinical-stage biotechnology company focused on cell therapy products for orthopaedic and bone diseases. Its lead candidate, ALLOB, is an allogeneic bone-forming cell therapy in development for delayed-union fractures, spinal fusion procedures, and revision spinal fusion. The company also develops PREOB, an autologous bone marrow-derived cell therapy for osteonecrosis and bone repair, and conducts preclinical research on next-generation combined cell-matrix products for large bone defects and maxillofacial applications. Bone Therapeutics targets orthopaedic surgeons, hospitals, and clinical specialists, primarily in Europe, and operates through partnerships and licensing arrangements with pharmaceutical and medical device companies. Its revenue model centers on research collaborations, grant funding, and potential milestone and royalty payments from partners, as it does not yet market approved products. The company is headquartered in Gosselies, Belgium.